Study on the treatment mode of inpatients with primary angle-closure glaucoma in China

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054643

Enrollment

Unknown

Registered

2021-12-22

Start date

2022-02-01

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary angle-closure glaucoma

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients hospitalized with primary angle-closure glaucoma as the main reason in China from 2011 to 2020; 2. Aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: 1. Due to the subjective or objective factors of the patient, the treatment was not completed as planned after admission (for example, the patient refused treatment, requested to be discharged, etc.); 2. Suffering from active keratitis, endophthalmitis and other eye inflammations at the same time; 3. The patient had undergone anti-glaucoma hand (excluding laser) and was readmitted due to poor intraocular pressure control after surgery; 4. Secondary angle-closure glaucoma.

Design outcomes

Primary

Measure	Time frame
uncorrected visual acuity;best-corrected visual acuity;intraocular pressure;number of anti-glaucoma medications;	—

Countries

China

Contacts

Public ContactLiang Yuanbo

Affiliated Eye Hospital of Wenzhou Medical University

yuanboliang@126.com+86 1825778686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026